Search Results - Lipton, Wendy L.

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Explaining Delinquent Involvement: a Consideration of Suppressor Effects

    Explaining Delinquent Involvement: a Consideration of Suppressor Effects by Lipton, Wendy L., Smith, M. Dwayne

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Social Involvement and the Resolution of Alcoholism

    Social Involvement and the Resolution of Alcoholism by Tuchfeld, Barry S., Lipton, Wendy L., Lile, Edward A.

    Published in Journal of drug issues
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Explaning Delinquent Involvement: A Consideration of Suppressor Effects

    Explaning Delinquent Involvement: A Consideration of Suppressor Effects by Lipton, Wendy L, Smith, M Dwayne

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia

    Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase... by Deininger, Michael W., Kopecky, Kenneth J., Radich, Jerald P., Kamel‐Reid, Suzanne, Stock, Wendy, Paietta, Elisabeth, Emanuel, Peter D., Tallman, Martin, Wadleigh, Martha, Larson, Richard A., Lipton, Jeffrey H., Slovak, Marilyn L., Appelbaum, Frederick R., Druker, Brian J.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Distinct Genetic Pathways Define Leukemia Predisposition Versus Adaptive Clonal Hematopoiesis in Shwachman-Diamond Syndrome

    Distinct Genetic Pathways Define Leukemia Predisposition Versus Adaptive Clonal Hematopoiesis in Shwachman-Diamond Syndrome by Kennedy, Alyssa L., Myers, Kasiani C., Bowman, James, Gibson, Christopher J., Muscato, Gwen M., Klein, Robert, Ballotti, Kaitlyn, Camarda, Nicholas, Furutani, Elissa M., Harris, Chad E., Liu, Shanshan, Galvin, Ashley, Malsch, Maggie, Dale, David C., Gansner, John M, Nakano, Taizo A., Bertuch, Alison A., Vlachos, Adrianna, Lipton, Jeff H., Castillo, Paul, Connelly, James, Edwards, John, Hijiya, Nobuko, Ho, Richard, Hofmann, Inga, Huang, James N, Keel, Sioban B., Lamble, Adam J., Lau, Bonnie W, Walkovich, Kelly J., Norkin, Maxim, Stock, Wendy, Boettcher, Steffen, Brendel, Christian, Stieglitz, Elliot, Fleming, Mark D., Davies, Stella M., Weller, Edie A., Bahl, Chris, Carter, Scott L., Shimamura, Akiko, Lindsley, R. Coleman

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening Program

    Self-Reported Questionnaire Detects Family History of Cancer in a Pancreatic Cancer Screening Program by Lucas, Aimee L., Tarlecki, Adam, Van Beck, Kellie, Lipton, Casey, RoyChoudhury, Arindam, Levinson, Elana, Kumar, Sheila, Chung, Wendy K., Frucht, Harold, Genkinger, Jeanine M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    IMATINIB 800MG DAILY INDUCES DEEPER MOLECULAR RESPONSES THAN IMATINIB 400MG DAILY: RESULTS OF SWOG S0325, AN INTERGROUP RANDOMIZED PHASE II TRIAL IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKAEMIA

    IMATINIB 800MG DAILY INDUCES DEEPER MOLECULAR RESPONSES THAN IMATINIB 400MG DAILY: RESULTS OF SWOG S0325, AN INTERGROUP RANDOMIZED PHASE II TRIAL IN NEWLY DIAGNOSED CHRONIC PHASE C... by Deininger, Michael W., Kopecky, Kenneth J., Radich, Jerald P., Kamel-Reid, Suzanne, Stock, Wendy, Paietta, Elisabeth, Emanuel, Peter D., Tallman, Martin, Wadleigh, Martha, Larson, Richard A., Lipton, Jeffrey H., Slovak, Marilyn L., Appelbaum, Frederick R., Druker, Brian J.

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    A Canadian Expanded Access Trial of Oral Nilotinb in Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

    A Canadian Expanded Access Trial of Oral Nilotinb in Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Ph... by Delage, Robert, Turner, A. Robert, Leber, Brian, Hasegawa, Wanda S., Roy, Denis-Claude, Savoie, Mary Lynn, Leitch, Heather A, Bence-Bruckler, Isabelle, Forrest, Donna L., Kanjeekal, Sindu, Sandeep, Sehdev, Laneuville, Pierre, Assouline, Sarit, Grewal, Kuljit, Kovacs, Michael J., Lam, Wendy, Woo, Annie, Beauparlant, Pierre, Lipton, Jeffrey H.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: